Anti-Human FCGRT Therapeutic Antibody (Rozanolixizumab)

Recombinant monoclonal antibody to FCGRT. Rozanolixizumab is a humanized and chimeric monoclonal antibody that can be potentially used in the treatment of Immunological diseases, Thrombocytopenia.
Supplier Creative Biolabs
Product # TAB-450CQ
Pricing Inquiry
Host Human
Target FCGRT
Species Reactivity Human
Type IgG4, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback